articleNatureMar 1, 2011Closed access

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

CSChristian SteidlSPSohrab P. ShahBWBruce W. WoolcockLRLixin RuiMKMasahiro Kawahara

National Cancer Institute · Center for Cancer Research · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

610
total citations
FWCI
27.33
Percentile
100%
References
45
Citations per year

Authors

27

Topics & keywords

Topics
Keywords
  • CIITA
  • Biology
  • Cancer research
  • Lymphoma
  • Major histocompatibility complex
  • MHC class II
  • Fusion gene
  • MHC class I
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.